Search bioRxiv⌕ Search

Biology subjects

Szori, K.

Publications and source records attributed to Szori, K..

2 recordsLinked to original sources

Green microwave-assisted extraction of Euphorbia guyoniana: Optimization, metabolite profile and in vivo anti-inflammatory potential

This study aimed to optimize microwave-assisted extraction of phenolic compounds from undervalued traditional plant Euphorbia guyoniana (Boiss. & Reut.) using central composite design of response surface methodology. The independent variables were extraction time (x1: 5 - 25 min), ethanol concentration in the extractive solvent (x2: 30 - 70%), microwave power (x3: 180 - 800 Watt) and feed-to-solvent ratio (x4: 1:7.5 - 1:17.5) while dependent variables were total phenolic content (TPC) and total flavonoid content (TFC). Extract obtained by using the optimal extraction parameters was evaluated for its in vivo anti-inflammatory activity by the carrageenan-induced paw edema model and was subjected to RP-HPLC-PDA-ESI-MS analysis to investigate the presence of phenolic compounds. The optimal conditions for highest TPC (377.22 {+/-} 5.42 mg GAE/100g) and TFC (184.40 {+/-} 1.18 mg QE/100g) were obtained at extraction time of 25 min, ethanol concentration of 40.57%, microwave power of 450 Watt and feed-to-solvent ratio of 1:17.5. The quadratic models significantly (p < 0.0001) fitted the experimental data with R2 values of 0.984 and 0.970 for TPC and TFC, respectively. Optimal extract of Euphorbia guyoniana significantly higher inhibited carrageenan induced inflammation with a concentration of 50 mg/kg (75,98%) when compared with reference anti-inflammatory drug ibuprofen (43,77%). Finally, above the previously reported phenolic constituents, i.e, quercetin and kaempferol derivatives, hydroxycinnamates have been identified for the first time in Euphorbia guyoniana plant extract.

plant biology↗

Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents

We describe herein the synthesis of eight new ester-coupled hybrid compounds from thymoquinone and protoflavone building blocks, and their bioactivity testing against multiple cancer cell lines. Among the hybrids, compound 14 showed promising activities in all cell lines studied. The highest activities were recorded against breast cancer cell lines with higher selectivity to MDA-MB-231 as compared to MCF-7. Even though the hybrids were found to be completely hydrolysed in 24 h under cell culture conditions, compound 14 demonstrated a ca. three times stronger activity against U-87 glioblastoma cells than a 1:1 mixture of its fragments. Protoflavone-thymoquinone hybrids may therefore serve as potential new antitumor leads particularly against glioblastoma.

pharmacology and toxicology↗